Related Experiment Video
Updated: Dec 17, 2025

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
Published on: January 29, 2011
Exhaled carbon monoxide levels in infants and toddlers with episodic asthma
Yoichiro Ohara1, Takahiro Ohara2, Koichi Hashimoto3
1Ohara Children's Clinic.
Insights
Exhaled carbon monoxide (eCO) levels can effectively evaluate asthma activity in infants and toddlers. This novel method aids in diagnosing asthma and assessing treatment response in young children.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Biomarker Research
Background:
- Limited lung function tests exist for evaluating bronchial asthma in infants and toddlers.
- Exhaled carbon monoxide (eCO) is a potential non-invasive biomarker for airway inflammation.
Purpose of the Study:
- To assess the applicability of exhaled carbon monoxide (eCO) measurements in evaluating stable asthma and acute asthma attacks in infants and toddlers.
- To test the hypothesis that eCO levels correlate with asthma status in young children.
Main Methods:
- A novel one-way valve breath sampling bag was developed for collecting exhaled air from infants and toddlers.
- A total of 483 participants were studied: 355 with asthma (182 with attacks, 173 asymptomatic), 119 with upper respiratory infection (URI), and 9 healthy controls.
Main Results:
- eCO levels were significantly higher in infants and toddlers during asthma attacks compared to asymptomatic asthma, URI, and healthy controls.
- eCO levels decreased significantly after therapy in children with asthma.
- eCO cut-off values demonstrated varying sensitivity and specificity in discriminating asthma attacks and diagnosing asthma in this age group.
Conclusions:
- Measurement of exhaled carbon monoxide (eCO) using a novel method is applicable for evaluating asthmatic activity in infants and toddlers.
- This method shows potential for assessing treatment responsiveness and aiding in the diagnosis of asthma in this population.
Objective:
There are few lung function tests available to evaluate bronchial asthma in infants and toddlers. The objective of this study was to test the hypothesis that the measurement of exhaled carbon monoxide (eCO) levels is applicable to evaluate infants and toddlers with stable asthma and during acute asthma attack.
Methods:
A one-way valve breath sampling bag was developed to collect the exhaled air of infants and toddlers. A total of 483 infants (under 2 years) and toddlers (2-5 years) were studied; 355 had an established diagnosis of asthma (182 suffering mild asthma attacks and 173 without active asthmatic symptoms), 119 had upper respiratory infection (URI) including acute bronchitis, and 9 were healthy.
Results:
In infants and toddlers, eCO levels of those with asthma attacks [median (interquartile range) = 2.0 (2.0-3.25) ppm, n=182] were significantly higher than those of subjects with asymptomatic asthma [2.0 (1.0-2.0) ppm, n=173, P < 0.0001], URI [2.0 (1.0-3.0) ppm, n=119, P < 0.0001], and healthy children [1.0 (0.0-1.0) ppm, n=9, P < 0.0001]. In 75 children with asthma petit mal, eCO levels during asthma attacks [3.0 (2.0-4.0) ppm] significantly decreased after therapy [1.0 (1.0-2.0) ppm, P < 0.0001]. In infants and toddlers with an established diagnosis of asthma (n=355), eCO cut-off >2 ppm discriminated asthma attack from an asymptomatic state with a sensitivity of 95.6%, a specificity of 43.3%, and an area under the curve (AUC) of 0.71 (95% CI:0.65-0.76, P < 0.0001). In 401 infants and toddlers with some respiratory symptoms, of which 285 cases were finally diagnosed as asthma [eCO level = 2.0 (2.0-3.0) ppm] and 116 cases were not asthma [eCO level = 2.0 (1.0-3.0) ppm, P < 0.0001], eCO cut-off >3 ppm supported the final diagnosis of asthma with a sensitivity of 38.9%, a specificity of 74.1%, and AUC of 0.63 (95% CI:0.56-0.69, P < 0.0001).
Conclusion:
The measurement of eCO by a novel method is applicable to evaluate asthmatic activity and treatment responsiveness, and to diagnose asthma in infants and toddlers.
Related Concept Videos
Asthma-III: Symptoms and Complications
Classification of Asthma
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Acute Respiratory Failure-III

